Advisory Board and Editors Pharmacology

PeerJ Factsheet
A one-page facts and stats PDF, to help when considering journal options with your co-authors.
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Fulvio D'Acquisto

Fulvio D'Acquisto graduated in pharmaceutical chemistry in 1993 from the University of Naples Federico II and was trained in pharmacology at the Department of Experimental Pharmacology of the Faculty of Pharmacy. He earned his Ph.D. degree in experimental pharmacology (1999).

During his postdoc at the Immunobiology section of Yale Medical School (1999-2004), he investigated the mechanisms by which TCR signaling leads to the activation of NF-kB. .

In 2006, he was appointed as a Senior Lecturer in Immunopharmacology within the Center for Biochemical Pharmacology at William Harvey Research Institute. He was conferred the title of Reader in Immunopharmacology in 2009 and Professor of Immunopharmacology in 2014.

He has been Deputy Director of the Centre for Biochemical Pharmacology of the William Harvey Research Institute from 2014 till 2017. During this period he has also been involved in the establishment of the Life Science Institute at QMUL and co-lead the biomedical research domain with Prof. R Pickersgill.

In 2017 he has been awarded an MA in Transpersonal Counselling and Psychotherapy from the University of Northampton for the study of dreams in patients suffering from autoimmune diseases. In the same year, he has moved to the University of Roehampton, Department of Life Science, to take up the position of Professor of Immunology where he is currently studying the links between emotional states and the immune inflammatory response.

Alberto Davalos

Group leader of the Epigenetics of Lipid Metabolism Group, IMDEA Food Institute, Dr. Alberto Dávalos holds a degree in Pharmacy and Biochemistry by San Marcos University (Lima) and a PhD in Pharmacy by Universidad Complutense de Madrid (Madrid).
He has conducted postdoctoral research at the Hospital Ramón y Cajal (Madrid), at Yale University School of Medicine, (New Haven), and at New York University School of Medicine (New York). Dr. Dávalos’s research program focuses in identifying and characterizing new noncoding RNAs (miRNAs, lncRNAs and other type of regulatory RNAs) that regulate lipid metabolism and the effects of minor dietary components (micronutrients) on their expression.

Maria A. Deli

Scientific advisor at the Institute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences in Szeged, Hungary. Head of the Biological Barriers Research Group. Honorary professor at the University of Szeged.

Chris J Garland

Professor of Vascular Pharmacology, University of Oxford and Fellow and Tutor in Medicine, Magdalen College, Oxford. Visiting Professor at the University of Queensland, Australia. Previously, Head and Professor of Pharmacology, University of Bath and Professor of Cardiovascular Pharmacology, University of Bristol. Visiting Professorships; University of Nagoya, Japan, Monash University, Australia and the National Academy of Sciences, Taiwan.

John Garthwaite

Professor of Experimental Neuroscience, Wolfson Inst for Biomedical Research, University College London.

Shawn M Gomez

Associate Professor, Joint Department of Biomedical Engineering at UNC-CH and NCSU; Joint Associate Professor, Department of Pharmacology, UNC-CH. Previous Florence Gould Scholar and Pasteur Foundation Fellow. Current research interests in systems and synthetic biology, bioimage informatics, and network science applied to biology. Broader interests in translational medicine and the fostering of innovative solutions to problems in healthcare.

Jorge Gonzalez Garcia

I obtained my PhD from the University of Valencia (Spain) focused on Supramolecular & Bioinorganic Chemistry, in which I worked in metalloenzymes mimetics and anion receptors. Upon completing my PhD in 2013, I performed several postdoctoral research positions in the University of Kansas (USA) and Institute Curie (France), in which I specialized in the development of drugs for non-canonical nucleic acids such as G-quadruplexes, triplexes or i-motifs. Then, I joined the Department of Chemistry at Imperial College London as Newton Fellow to develop new tools to target and visualize G-quadruplexes in cells. I continued my projects as IdEx Fellow in the European Institute of Chemistry and Biology in Bordeaux (France). Actually, I’ve started my team in the Institute of Molecular Science in the University of Valencia, where I’ve developed novel systems and methodologies to target non-canonical DNA structures and unravel their biological roles.

Elena González-Burgos

Assistant professor of Pharmacology and Pharmacognosy at University Complutense of Madrid. Member of the Research Group “Pharmacology of Natural Products”. I obtained my European PhD in Pharmacy in 2012 (Extraordinary Doctoral Prize). I had worked for 3 years in the Spanish Agency of Medicines and Medical Devices (AEMPS). Expertise in the study of natural products from medicinal plants and lichens as neuroprotective agents, based on their antioxidant properties, against different models of oxidative stress in cell lines of the nervous system (neurons and astrocytes). Author of many scientific publications (25 in indexed journals, 4 in non-indexed journals and 9 chapters of books) as well as communications in national and international congresses. I have participated as researcher in four National funded projects and research stays at prestigious international centers (King’s College of London and Neuroscience Center in Coimbra). Teaching experience at all levels of higher education in Pharmacology, Toxicology and Pharmacognosy subjects as well as experience in Educational Innovative Projects.

John Gordon

Co-founder and CSO of Celentyx Ltd.
Professor Emeritus of Cellular Immunology and Head of College of Medical and Dental Sciences Graduate School, University of Birmingham.
Raine Visiting Professor, University of Western Australia.

John Gordon is an internationally recognised authority on immune cell biology and immune cell-mediated diseases. For the past decade or so, John has been pioneering the field of Neuro-Immuno-Pharmacology. He is one of the world’s most highly cited researchers (www.ISIHighlyCited.com) and has a proven track record in the successful application of research within the field of translational medicine.

Wolfgang F Graier

Previously the Chair of the Institute of Molecular Biology and Biochemistry, Medical University of Graz, Austria.

Expertise in Vascular Cell Biology, Intracellular Ion Mesaurements (e.g. Ca2+), Organelle Function (Mitochondria, ER), Live-cell Imaging, Confocal microscopy, Electrophysiology, Cell Physiology, Development of Biosensors, Signal Transduction,
Cell Biology, Energy metabolism, Aging.

Thomas Hartung

Professor of Toxicology (Chair for Evidence-based Toxicology), Pharmacology, Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health, Baltimore, and University of Konstanz, Germany; Director of their Centers for Alternatives to Animal Testing (CAAT). Former Head of the European Center for the Validation of Alternative Methods (ECVAM), Ispra, Italy.

Noriko F Hiroi

Noriko Hiroi is Assistant Professor of the Department of Biosciences and Informatics, Keio University. She started to develop her career in Molecular Biology and Biochemistry, and currently works in Systems Biology and Quantitative Biology area. Her research interest includes in vivo oriented modelling, molecular mechanisms of higher-functions of central nerve systems, microfluidics technology and optical technologies and informatics for bioimaging.